BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dijk PRV, Logtenberg SJ, Groenier KH, Haveman JW, Kleefstra N, Bilo HJ. Complications of continuous intraperitoneal insulin infusion with an implantable pump. World J Diabetes 2012; 3(8): 142-148 [PMID: 22912916 DOI: 10.4239/wjd.v3.i8.142]
URL: https://www.wjgnet.com/1948-9358/full/v3/i8/142.htm
Number Citing Articles
1
S. I. Lee, P. Narendran. Intraperitoneal insulin therapy for a patient with type 1 diabetes with insulin injection site inflammationCase Reports 2014; 2014(aug21 1): bcr2014205278 doi: 10.1136/bcr-2014-205278
2
Justin M. Gregory, Alan D. Cherrington, Daniel J. Moore. The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 DiabetesDiabetes 2020; 69(5): 837 doi: 10.2337/dbi19-0026
3
Marga Giménez, Sanjay Purkayajtha, Vanessa Moscardó, Ignacio Conget, Nick Oliver. Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?Endocrinología, Diabetes y Nutrición 2018; 65(3): 182 doi: 10.1016/j.endinu.2018.01.001
4
Marga Giménez, Sanjay Purkayajtha, Vanessa Moscardó, Ignacio Conget, Nick Oliver. Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?Endocrinología, Diabetes y Nutrición (English ed.) 2018; 65(3): 182 doi: 10.1016/j.endien.2018.03.007
5
Hyunjoo J. Lee, Nakwon Choi, Eui-Sung Yoon, Il-Joo Cho. MEMS devices for drug deliveryAdvanced Drug Delivery Reviews 2018; 128: 132 doi: 10.1016/j.addr.2017.11.003
6
William V. Tamborlane, Miladys M. Palau-Collazo. International Textbook of Diabetes Mellitus2015; : 765 doi: 10.1002/9781118387658.ch51
7
Melanie R. Nilsson. Insulin amyloid at injection sites of patients with diabetesAmyloid 2016; 23(3): 139 doi: 10.1080/13506129.2016.1179183
8
P.R. van Dijk, S.J.J. Logtenberg, R.O.B. Gans, H.J.G. Bilo, N. Kleefstra. Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemiaClinical Endocrinology 2014; 81(4): 488 doi: 10.1111/cen.12546
9
Rosa Garcia-Verdugo, Michael Erbach, Oliver Schnell. A New Optimized Percutaneous Access System for CIPIIJournal of Diabetes Science and Technology 2017; 11(4): 814 doi: 10.1177/1932296817694913
10
Keith R. Hildebrand. Drug-Device Combinations For Chronic Diseases2015; : 182 doi: 10.1002/9781119002956.ch07
11
K. T. D. Yeung, M. Reddy, S. Purkayastha. Surgical options for glycaemic control in Type 1 diabetesDiabetic Medicine 2019; 36(4): 414 doi: 10.1111/dme.13885
12
Mohammad Fakhroleslam, Ramin Bozorgmehry Boozarjomehry. A multi‐objective optimal insulin bolus advisor for type 1 diabetes based on personalized model and daily dietAsia-Pacific Journal of Chemical Engineering 2021;  doi: 10.1002/apj.2651
13
Vladimir Aleksandrovich Karpel'ev, Elena Anatol'evna Fedorova, Yury Ivanovich Philippov, Aleksandr Yur'evich Mayorov, Marina Vladimirovna Shestakova. Intraperitoneal insulin infusion: on the way to the artificial pancreasDiabetes mellitus 2015; 18(3): 32 doi: 10.14341/DM2015332-45
14
Lia Bally, Hood Thabit, Roman Hovorka. Finding the right route for insulin delivery – an overview of implantable pump therapyExpert Opinion on Drug Delivery 2017; 14(9): 1103 doi: 10.1080/17425247.2017.1267138
15
Jordan Magisson, Aladin Sassi, Aram Kobalyan, Charles-Thibault Burcez, Richard Bouaoun, Michel Vix, Nathalie Jeandidier, Severine Sigrist. A fully implantable device for diffuse insulin delivery at extraperitoneal site for physiological treatment of type 1 diabetesJournal of Controlled Release 2020; 320: 431 doi: 10.1016/j.jconrel.2020.01.055
16
E. Zini, I. Padrutt, K. Macha, A. Riederer, M. Pesaresi, T.A. Lutz, C.E. Reusch. Use of an implantable pump for controlled subcutaneous insulin delivery in healthy catsThe Veterinary Journal 2017; 219: 60 doi: 10.1016/j.tvjl.2016.12.006
17
Maggie J. Malone-Povolny, Taron M. Bradshaw, Elizabeth P. Merricks, C. Tyler Long, Timothy C. Nichols, Mark H. Schoenfisch. Combination of Nitric Oxide Release and Surface Texture for Mitigating the Foreign Body ResponseACS Biomaterials Science & Engineering 2021; 7(6): 2444 doi: 10.1021/acsbiomaterials.1c00022